SK280508B6 - Deriváty 2-kyano-3-hydroxypropénamidov, spôsoby ic - Google Patents

Deriváty 2-kyano-3-hydroxypropénamidov, spôsoby ic Download PDF

Info

Publication number
SK280508B6
SK280508B6 SK1495-93A SK149593A SK280508B6 SK 280508 B6 SK280508 B6 SK 280508B6 SK 149593 A SK149593 A SK 149593A SK 280508 B6 SK280508 B6 SK 280508B6
Authority
SK
Slovakia
Prior art keywords
formula
cyano
cyclopropyl
hydroxy
propenamide
Prior art date
Application number
SK1495-93A
Other languages
English (en)
Slovak (sk)
Other versions
SK149593A3 (en
Inventor
Elizabeth A. Kuo
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SK149593A3 publication Critical patent/SK149593A3/sk
Publication of SK280508B6 publication Critical patent/SK280508B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1495-93A 1993-01-05 1993-12-29 Deriváty 2-kyano-3-hydroxypropénamidov, spôsoby ic SK280508B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300083A GB9300083D0 (en) 1993-01-05 1993-01-05 Chemical compounds

Publications (2)

Publication Number Publication Date
SK149593A3 SK149593A3 (en) 1994-12-07
SK280508B6 true SK280508B6 (sk) 2000-03-13

Family

ID=10728304

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1495-93A SK280508B6 (sk) 1993-01-05 1993-12-29 Deriváty 2-kyano-3-hydroxypropénamidov, spôsoby ic

Country Status (33)

Country Link
US (1) US5346912A (cs)
EP (1) EP0606175B1 (cs)
JP (1) JP3334988B2 (cs)
KR (1) KR100295717B1 (cs)
CN (1) CN1042935C (cs)
AT (1) ATE128968T1 (cs)
AU (1) AU663017B2 (cs)
BR (1) BR9400017A (cs)
CA (1) CA2112866C (cs)
CZ (1) CZ283948B6 (cs)
DE (1) DE69400024T2 (cs)
DK (1) DK0606175T3 (cs)
EE (1) EE03001B1 (cs)
ES (1) ES2078130T3 (cs)
FI (1) FI106553B (cs)
GB (1) GB9300083D0 (cs)
GR (1) GR3017723T3 (cs)
HR (1) HRP940006B1 (cs)
HU (1) HU216835B (cs)
IL (1) IL107788A (cs)
LT (1) LT3766B (cs)
LV (1) LV10712B (cs)
MX (1) MX9400274A (cs)
NO (1) NO300839B1 (cs)
NZ (1) NZ250520A (cs)
PL (1) PL175135B1 (cs)
RU (1) RU2126387C1 (cs)
SI (1) SI9300686A (cs)
SK (1) SK280508B6 (cs)
TW (1) TW259785B (cs)
UA (1) UA40573C2 (cs)
YU (1) YU49047B (cs)
ZA (1) ZA939118B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002521441A (ja) * 1998-07-28 2002-07-16 スミスクライン・ビーチャム・コーポレイション Ccr5モジュレーターとしてのプロペンアミド
EP2583678A3 (en) 2004-06-24 2013-11-13 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
RU2516290C2 (ru) 2007-08-27 2014-05-20 Басф Се Пиразольные соединения и их использование в способе борьбы с беспозвоночными вредителями, в способе защиты материала размножения растений, в способе лечения или защиты животных от инвазии или инфицирования, в материале размножения растений и сельскохозяйственные композиции, содержащие пиразольные соединения
EP2342196B1 (en) 2008-09-24 2015-07-29 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2011003796A1 (en) 2009-07-06 2011-01-13 Basf Se Pyridazine compounds for controlling invertebrate pests
EP2451808B1 (en) 2009-07-06 2014-03-26 Basf Se Pyridazine compounds for controlling invertebrate pests
BR112012001597A2 (pt) 2009-07-24 2015-09-01 Basf Se Método para controlar e/ou combater pestes de invertebrados, método para a proteção do material de propagação de planta e/ou das plantas que crescem do mesmo, material de propagação de planta e método para tratar ou proteger um animal de infestação ou infecção por parasitas
US20160287549A1 (en) 2013-11-22 2016-10-06 Genzyme Corporation Novel methods for treating neurodegenerative diseases
CN105693574B (zh) * 2014-11-25 2017-12-19 中国科学院大连化学物理研究所 2‑烷硫基烯酰胺衍生物及其合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
ES492686A0 (es) * 1980-06-23 1981-06-01 Made Labor Sa Un metodo para la produccion industrial de n-(4-piridilme- til)-benzamidas
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
DE3534440A1 (de) 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4888357A (en) 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
EP0527736B1 (de) * 1990-05-18 1997-04-16 Hoechst Aktiengesellschaft Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-cycloalkyl-propanamides their tautomer forms and their salts preparation process and compositions containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf 3-Cycloalkyl-prop-2- enamide derivatives

Also Published As

Publication number Publication date
SK149593A3 (en) 1994-12-07
HU9400033D0 (en) 1994-05-30
YU49047B (sh) 2003-07-07
RU2126387C1 (ru) 1999-02-20
CN1097005A (zh) 1995-01-04
EP0606175A1 (fr) 1994-07-13
EE03001B1 (et) 1997-06-16
HU216835B (hu) 1999-09-28
UA40573C2 (uk) 2001-08-15
CZ283948B6 (cs) 1998-07-15
JPH06211793A (ja) 1994-08-02
ES2078130T3 (es) 1995-12-01
NO940020D0 (no) 1994-01-04
IL107788A0 (en) 1994-02-27
DK0606175T3 (da) 1996-02-19
US5346912A (en) 1994-09-13
LV10712B (en) 1995-12-20
AU663017B2 (en) 1995-09-21
NO940020L (cs) 1994-07-06
HUT71471A (en) 1995-11-28
CN1042935C (zh) 1999-04-14
BR9400017A (pt) 1994-08-02
CA2112866C (fr) 2007-03-13
GB9300083D0 (en) 1993-03-03
FI940031L (fi) 1994-07-06
NO300839B1 (no) 1997-08-04
EP0606175B1 (fr) 1995-10-11
DE69400024T2 (de) 1996-04-04
HRP940006A2 (en) 1996-10-31
FI106553B (fi) 2001-02-28
JP3334988B2 (ja) 2002-10-15
LV10712A (lv) 1995-06-20
MX9400274A (es) 1994-08-31
ATE128968T1 (de) 1995-10-15
FI940031A0 (fi) 1994-01-04
KR100295717B1 (ko) 2001-11-05
KR940018363A (ko) 1994-08-16
CA2112866A1 (fr) 1994-07-06
SI9300686A (en) 1994-09-30
PL175135B1 (pl) 1998-11-30
LT3766B (en) 1996-03-25
HRP940006B1 (en) 1999-12-31
LTIP1634A (en) 1995-02-27
CZ292193A3 (en) 1994-07-13
AU5213093A (en) 1994-07-14
DE69400024D1 (de) 1995-11-16
NZ250520A (en) 1996-08-27
RU94000064A (ru) 1996-07-10
TW259785B (en) 1995-10-11
GR3017723T3 (en) 1996-01-31
ZA939118B (en) 1995-01-18
YU82593A (sh) 1996-07-24
PL301774A1 (en) 1994-07-11
IL107788A (en) 1998-08-16

Similar Documents

Publication Publication Date Title
EP0405425B1 (en) Heteroarylamino- and heteroaryloxypyridinamines and related compounds, a process for their preparation and their use as medicaments
MXPA06007077A (es) Derivados de bencenosulfonilamino-piridin-2-ilo y compuestos relacionados como inhibidores de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 para el tratamiento de diabetes y obesidad.
DE69107959T2 (de) 3-Cycloalkylpropansäureamide, ihre Tautomere und Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen.
CS208153B2 (en) Method of making the 5-/4-pyridyl/-6-/4-fluorphebyl/-2,3-dihydroimidazo 2,1-b thiazole
CZ287768B6 (en) Amides of sulfonamidocarbonylpyridine-2-carboxylic acids, process of their preparation and medicaments based thereon
CZ289536B6 (cs) Esteramidy sulfonamidokarbonylpyridin-2-karboxylových kyselin, způsob jejich přípravy
SK280508B6 (sk) Deriváty 2-kyano-3-hydroxypropénamidov, spôsoby ic
JPH0788387B2 (ja) 新規な4H―トリアゾロ〔4,3―a〕〔1,4〕ベンゾジアゼピン類、それらの製造法及び薬剤としての使用
CA2133140C (en) Isoxazole derivatives
EP0030009A1 (en) New derivatives of the 9-cis-6,6'-diapo-psi,psi-carotenedioic acid, preparation thereof and pharmaceutical compositions containing same
PL84190B1 (en) 3-aroyl-alkenyleneimines[us3835149a]
SE436359B (sv) Analogiforfarande for framstellning av 4-substituerade imidazo/1,2-a/kinoxaliner
JPH07278148A (ja) イミダゾピラゾール誘導体
JPH0649047A (ja) フェニルカルボキサミドイソオキサゾールの新誘導体及びそれらの塩類、それらの製造法及びこの製造法の新規な中間体、それらの薬剤としての用途並びにそれらを含有する製薬組成物
JPH07188145A (ja) 芳香族アミド
JPS63243074A (ja) ピリジンの新誘導体、それらの製造法及び中間体、薬剤としての使用並びにそれらを含む組成物
DE69402004T2 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
NO177187B (no) Analogifremgangsmåte for fremstilling av terapautisk aktive N,N'-bis(alkoksy-alkyl)-pyridin-2,4-dikarboksylsyrediamider
JP3145803B2 (ja) 3−シクロアルキル−2−プロペンアミド誘導体
US4021436A (en) Derivatives of nicotinic acid with amines variously substituted
IL296631A (en) Phd inhibitor compounds, compositions, and use
Medina-Mercado et al. 2-Trifluoromethyl-1, 3-diazabutadienes as useful intermediates for the construction of 2-trifluoromethylpyrimidine derivatives
US3914246A (en) Tri-substituted imidazoles
JPS6136285A (ja) ニトロアポビンカミン酸誘導体、それを含有する医薬組成物、およびそれらの製法
IE47789B1 (en) Thieno(3,2-c)and thieno(2,3-c)pyridines,process for their preparation and therapeutic composition containing them

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20131229